Results
1 -
10 of
21Imidafenacin has no influence on learning in nucleus basalis of Meynert-lesioned rats, Naunyn-Schmiedeberg's Archives of Pharmacology Temporary cognitive impairment related to administration of newly developed anticholinergic medicines for overactive bladder: two case reports, BMC Research Notes Perception of Incontinence in and by Society, Urinary and Fecal Incontinence Small Animal Imaging with Positron Emission Tomography, Molecular Imaging in the Clinical Neurosciences In vivo bladder selectivity of imidafenacin, a novel antimuscarinic agent, assessed by using an effectiveness index for bladder capacity in rats, Naunyn-Schmiedeberg's Archives of Pharmacology Comparative functional selectivity of imidafenacin and propiverine, antimuscarinic agents, for the urinary bladder over colon in conscious rats, Naunyn-Schmiedeberg's Archives of Pharmacology Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline?, International Urogynecology Journal Add-on anticholinergic therapy for residual nocturia in patients with lower urinary tract symptoms receiving ??1-blocker treatment: a multi-centre, prospective, randomised study, World Journal of Urology Imidafenacin on bladder and cognitive function in neurologic OAB patients, Clinical Autonomic Research Factors influencing efficacy endpoints in clinical trials for new oral medicinal treatments for overactive bladder: a systematic literature review and meta-analysis, International Urology and Nephrology